BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Adipose tissue
,
Human chorionic gonadotropin
,
Aspirin
,
rs3825942
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
KRAS 1
Summary
General Info
Curated Studies
Most Correlated Studies
T-lineage acute lymphoblastic leukemia (T-ALL) xenografts treated with GDC-0941 and PD 0325901
Lung cancer A549 cells (KRAS mutant) after BI-2536 and fasudil combination treatment
Acute myelogenous leukemia cells expressing activated NRAS treated with RAS pathway inhibitors
Prostate cancer mouse models treated with different compounds
RPE-1 hTERT and UM-UC-3 cells with RAS mutation treated with prexasertib & gemcitabine
Explore Curated Studies Results
Literature
Most Relevant Literature
Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer p…
Integrin-linked kinase (ILK) regulates KRAS, IPP complex and Ras suppressor-1 (RSU1) promoting lung …
Lymphatic Malformations in Parkes Weber Syndrome: Retrospective Review of Sixteen Cases in a Vascula…
Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy.
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl acciden…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
A Phase 1, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locall…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ